Portola Pharmaceuticals Overview

  • Founded
  • 2003
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 408
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1.42B
Latest Deal Amount

Portola Pharmaceuticals General Information

Description

Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Contact Information

Website
www.portola.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Parent Company
Primary Office
  • 270 East Grand Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Portola Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 02-Jul-2020 $1.42B 00000 00.000 Completed Generating Revenue/Not Profitable
14. Secondary Transaction - Open Market 00000 Completed Generating Revenue
13. Secondary Transaction - Open Market 30-Jun-2018 00000 Completed Generating Revenue
12. PIPE 03-Feb-2017 0000 00000 Completed Generating Revenue
11. PIPE 25-Jan-2016 00000 Completed Generating Revenue
10. Secondary Transaction - Stock Distribution 18-Feb-2014 000.00 00000 Completed Generating Revenue
9. 2PO 17-Oct-2013 00000 00000 00000 Completed Generating Revenue
8. IPO 22-May-2013 00000 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series 1) 14-Dec-2011 $8.99M $338M Completed Generating Revenue
6. Later Stage VC (Series D) 21-Nov-2011 $89M $329M 00000 Completed Generating Revenue
To view Portola Pharmaceuticals’s complete valuation and funding history, request access »

Portola Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series 1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series B 36,750,400 $0.001000 8% $1.31 $1.31 1x $1.31 12.25%
Series A 43,147,400 $0.001000 8% $1 $1 1x $1 14.38%
To view Portola Pharmaceuticals’s complete cap table history, request access »

Portola Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Portola Pharmaceuticals Inc is a biotechnology company focused on developing and commercializing novel therapeutics. The
Pharmaceuticals
South San Francisco, CA
408 As of 2019
00000
0.000 0000-00-00
000000&0 00000

00000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000000000000
Charlottesville, VA
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Portola Pharmaceuticals Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
000000000 00000000 Formerly VC-backed Charlottesville, VA 00 000.00 00000000 000.00
0000000 Formerly VC-backed Summit, NJ 0000 000.00 000000&0 000.00
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
0000000 0000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
You’re viewing 5 of 42 competitors. Get the full list »

Portola Pharmaceuticals Executive Team (15)

Name Title Board Seat Contact Info
Glenn Brame Executive Vice President & Chief Technical Operations Officer
You’re viewing 1 of 15 executive team members. Get the full list »

Portola Pharmaceuticals Board Members (21)

Name Representing Role Since
Jeffrey Bird Ph.D Sutter Hill Ventures Board Member 000 0000
John Johnson Self Board Member, Chairman of Compensation Committee & Member of Nominating and Corporate Governance Committee 000 0000
Ward Wolff Portola Pharmaceuticals Board Member & Chairman of Audit Committee 000 0000
You’re viewing 3 of 21 board members. Get the full list »

Portola Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Portola Pharmaceuticals Former Investors (35)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abingworth Management Venture Capital Minority 000 0000 000000 0
Adage Capital Management Hedge Fund Minority 000 0000 000000 0
Advanced Technology Ventures Venture Capital Minority 000 0000 000000 0
AllianceBernstein Asset Manager Minority 000 0000 000000 0
Alta Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 35 investors. Get the full list »

Portola Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 10-May-2007 00000 00000 00 000.00 Drug Discovery
To view Portola Pharmaceuticals’s complete investments history, request access »

Portola Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 10-May-2007 00000 00000 00 000.00 Completed
  • 6 buyers
To view Portola Pharmaceuticals’s complete exits history, request access »